Emmecell
Emmecell34About
What does Emmecell do?
Emmecell is a biotechnology company developing a proprietary Magnetic Cell Delivery nanoparticle platform to address challenges in localizing, retaining, and integrating cell therapies. This platform aims to improve regenerative medicine by enabling precise delivery of cells to target tissues. Emmecell is initially focusing its efforts on ophthalmic indications.
What is Emmecell's revenue?
StartupHub estimates Emmecell's annual revenue at $1.2M (range $697K to $4.1M, 69% confidence), based on comparable companies in the sector.
Where is Emmecell headquartered?
Emmecell is headquartered in Menlo Park, California, USA.
When was Emmecell founded?
Emmecell was founded in 2016.
What industry does Emmecell operate in?
Emmecell operates in Biotechnology, HealthTech, Medical Devices, Biotech, MedTech, Drug Discovery.
How many employees does Emmecell have?
Emmecell has approximately 12 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.